CTKB Stock Analysis: Buy, Sell, or Hold?
CTKB - Cytek Biosciences, Inc. Common Stock
$3.41
0.05 (1.49%)
▲
5d:
-26.14%
30d:
-26.14%
90d:
-19.69%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CTKB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CTKB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CTKB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CTKB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: CTKB is currently trading at $3.40, which is considered oversold relative to its 30-day fair value range of $4.08 to $4.83. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.9) compared to its historical average (87.5). Remarkably, the market is currently pricing in an annual earnings decline of 41.1% over the next few years. This pessimistic expectation contrasts with the company's recent 73.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CTKB is in a downtrend. The price is currently testing key support at $3.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CTKB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.69 (+67.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CTKB is in a downtrend. The price is currently testing key support at $3.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CTKB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.69 (+67.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.08 -
$4.83
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 67.0% below Wall St target ($5.69)
- CAUTION: 5-day price weakness (-26.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.08 -
$4.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.31
Resistance Level
$4.99
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.92
Wall Street Target
$5.69
(+67.0%)
Revenue Growth (YoY)
6.5%
Earnings Growth (YoY)
73.5%
Profit Margin
-36.2%
Valuation Discount vs History
-41.1% cheaper
PE vs Historical
17.9 vs 87.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-41.1%
(market-implied from PE analysis)
1-Year Target
$3.06
(-10%)
2-Year Target
$2.76
(-19%)
3-Year Target
$2.48
(-27%)
3-Yr Target (if PE normalizes)
(PE: 18→88)
$12.12
(+256%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.9 to 87.5
Stabilization Target:
$16.62
(+388.3%)
PE Expansion Potential:
+388.3%
Share & Embed Analysis
Last updated: May 18, 2026 4:09 AM ET
Data refreshes hourly during market hours. Next update: 5:09 AM
Data refreshes hourly during market hours. Next update: 5:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTKB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
